This blog covers topics of interest to Food and Drug Administration-regulated companies, fellow food and drug and health-care lawyers and regulatory personnel, as well as people just generally interested in FDA law. The blog provides timely updates on FDA enforcement actions, proposed rules, personnel changes, new and improved policies, along with related issues such as health-care fraud and abuse, drug and device reimbursement, HIPAA, and other topics of interest.
Jotwell—which stands for Journal of Things We Like (Lots)—features relatively brief law prof-authored reviews of recent scholarly articles in plain English.
